CONSORT extension. CONSORT for Non-pharmacologic interventions. Isabelle Boutron

Similar documents
Reporting guidelines

Other potential bias. Isabelle Boutron French Cochrane Centre Bias Method Group University Paris Descartes

The influence of CONSORT on the quality of reports of RCTs: An updated review. Thanks to MRC (UK), and CIHR (Canada) for funding support

Methods in Research on Research. The Peer Review Process. Why Evidence Based Practices Are Needed?

Spin in research publications

The SPIRIT Initiative: Defining standard protocol items

Randomized clinical trials (RCTs) are usually considered

Impact of adding a limitations section to abstracts of systematic reviews on readers interpretation: a randomized controlled trial

The EQUATOR Network: a global initiative to improve the quality of reporting research

Dissemination experiences from CONSORT and other reporting guidelines

Improving reporting for observational studies: STROBE statement

THE REPORTING OF HARM IS AS

The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews

RoB 2.0: A revised tool to assess risk of bias in randomized trials

CONSORT 2010 checklist of information to include when reporting a randomised trial*

Reporting methodological items in randomised

From protocol to publication: ensuring quality in the reporting of continence research Workshop 20 Monday, August 23rd 2010, 14:00 17:00

Web appendix (published as supplied by the authors)

Garbage in - garbage out? Impact of poor reporting on the development of systematic reviews

EQUATOR Network: promises and results of reporting guidelines

Issues to Consider in the Design of Randomized Controlled Trials

Reporting methodological items in randomised

Evidence across diverse medical fields suggests that the

PROTOCOL: Reporting Guidelines Systematic Review 1. Dr. David Moher

Reducing waste in research

Translating research findings and evidence-based guidelines into clinical practice

cohort study case-control study cross-sectional study benefit transparency credibility randomized controlled trial: RCT critical assessment

Time for quality of manual physical therapy Where do we stand now and are we moving in the right direction?

Meeting the research information needs of patients and clinicians more effectively Iain Chalmers Editor, James Lind Library

Randomized Controlled Trial

N of 1 trials: planning, conduct, and evaluation

Announcement of revised tools to assess risk of bias in randomized trials and in non-randomized studies

User s guide to the checklist of items assessing the quality of randomized controlled trials of nonpharmacological treatment

IMPORTANCE OF AND CRITERIA FOR EVALUATING EXTERNAL VALIDITY. Russell E. Glasgow, PhD Lawrence W. Green, DrPH

Statistical Analysis Plans

METHODOLOGICAL INDEX FOR NON-RANDOMIZED STUDIES (MINORS): DEVELOPMENT AND VALIDATION OF A NEW INSTRUMENT

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Research Quality of reporting of randomized controlled trials in polycystic ovary syndrome Anna Partsinevelou 1 and Elias Zintzaras* 1,2

Downloaded from:

Instrument for the assessment of systematic reviews and meta-analysis

Guidelines for Reporting Non-Randomised Studies

Well-designed, properly conducted, and clearly reported randomized controlled

Effectiveness of START psychological intervention in reducing abuse by dementia family carers: randomized controlled trial

Health authorities are asking for PRO assessment in dossiers From rejection to recognition of PRO

Blinding in Randomized Controlled Trials: What researchers need to know?

Eldridge, SM, Chan, CL, Campbell, MJ, Bond, CM, Hopewell, S, Thabane, L and Lancaster, GA

Levels of evidence: a comparison between top medical journals and general pediatric journals

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments

Many questions in medical research are investigated in

Role of evidence from observational studies in the process of health care decision making

Korea-China Editorial Workshop

Design considerations for clinical trials of nonpharmacological

EBP STEP 2. APPRAISING THE EVIDENCE : So how do I know that this article is any good? (Quantitative Articles) Alison Hoens

Smoke and mirrors: where is the K for KT? Jeremy Grimshaw MD, PhD

Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals

Reporting randomised trials of social and psychological interventions: the CONSORT- SPI 2018 Extension

STRICTA: is it time to do more?

Avoidable waste of research related to inadequate methods in clinical trials

SUPPLEMENTAL DIGITAL CONTENT Improving reporting of behavioural interventions: WIDER Consensus Statement

CONSORT: missing missing data guidelines, the effects on HTA monograph reporting Yvonne Sylvestre

Reporting quality of randomized controlled trial abstracts presented at European Orthodontic Society congresses

Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals

CONSORT 2010 Statement Annals Internal Medicine, 24 March History of CONSORT. CONSORT-Statement. Ji-Qian Fang. Inadequate reporting damages RCT

Learning from Systematic Review and Meta analysis

Systematic Reviews. Simon Gates 8 March 2007

Systematic reviewers neglect bias that results from trials stopped early for benefit

What you need to know about pilot studies: the what, why and how

White Rose Research Online URL for this paper:

Critical Appraisal of RCT

PROSPERO International prospective register of systematic reviews

Title 1 Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym

Supplementary Online Content

Original Article. and non-consort-endorsing

A Cochrane systematic review of interventions to improve hearing aid use

Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review

RESEARCH. Reporting of sample size calculation in randomised controlled trials: review

Authors Introduction to Pragmatic Trials. and Stepped Wedge Designs. Sandra Eldridge

Epidemiology and Reporting Characteristics of Systematic Reviews

RARE-Bestpractices Conference

4/10/2018. Choosing a study design to answer a specific research question. Importance of study design. Types of study design. Types of study design

National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator

Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review

APPLYING EVIDENCE-BASED METHODS IN PSYCHIATRY JOURNAL CLUB: HOW TO READ & CRITIQUE ARTICLES

Methodological issues

The Cochrane-REWARD prize for reducing waste in research

Early add-on treatment vs alternative monotherapy in patients with partial epilepsy

DMRI Drug Misuse Research Initiative

Controlled Trials. Spyros Kitsiou, PhD

Impact of STARD on reporting quality of diagnostic accuracy studies in a top Indian Medical Journal: A retrospective survey

Best Practice & Research Clinical Rheumatology

THE EFFICACY-EFFECTIVENESS DISTINCTION IN TRIALS OF ALCOHOL BRIEF INTERVENTIONS

The importance of good reporting of medical research. Doug Altman. Centre for Statistics in Medicine University of Oxford

Example of a Systematic Review and its application to practice

Clinical Study Design: From Pilot to Randomized Controlled Trials

Introduction to Evidence-Based Medicine

Clinical Practice Guidelines: Clinical Practice Guidelines Can t Live With Them; Can t Live Without Them

Protocol Development: The Guiding Light of Any Clinical Study

Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade?

Fang Hua 1,2*, Tanya Walsh 2, Anne-Marie Glenny 2 and Helen Worthington 2*

Transcription:

EQUATOR Network seminar CONSORT extension CONSORT for Non-pharmacologic interventions Isabelle Boutron Center of Clinical Epidemiology French Cochrane center Hôtel Dieu Hospital 1

An extension for non-pharmacologic treatments Why? Non-pharmacologic treatments (NPT) concern a large variety of treatments Therapist-dependent interventions - surgery - technical operation (arthroscopy, ) Participative interventions - rehabilitation - education Non implantable devices - orthopedic braces or orthosis - laser treatment

An extension for non-pharmacologic treatments Why? Placebo Placebo of surgery? Placebo of psychotherapy? Blinding Feasibility of blinding Success of blinding Boutron I et al. JCE 2004 3

An extension for non-pharmacologic treatments Why? Standardization - Specific training - Quality control procedures Intervention Multiple components Fidelity Gap between the - intended - administered intervention Centre Halm et al, Ann Intern Med 2002 -Procedure - Drug - Anesthesia - Education - Rehabilitation - etc. Care providers 4

Percentage of studies with sufficient description of initial treatment (based only on the published paper) and after supplementary information was obtained from authors. Glasziou P et al. BMJ 2008 Copyright 2008 BMJ Publishing Group Ltd. 5

An extension for non-pharmacologic treatments Why? Study of surgical papers (n = 158) published in 2004 Reporting of details of the intended intervention Surgical procedure 87 % Pre-operative care 15 % Anesthesia 35 % Post-operative care 49 % Surgeons Selection criteria for surgeon 40 % Number of surgeons involved 33 % Number of interventions performed by surgeon 11 % Jacquier I, Boutron I, Ravaud P, Ann. Surgery, 2006 6

An extension for non-pharmacologic treatments. The process. 30 experts Surgeons (n = 7) Clinicians involved in rehabilitation (n = 1) Clinicians involved in education (n = 1) Clinicians involved in psychotherapy (n = 2) Clinical epidemiologists, biostatisticiens (n = 14) Editors (n = 5) Preliminary survey To identify items to be discussed based the experts opinion Consensus meeting in Paris (2006) To achieve consensus on a modified checklist 7

An extension for non-pharmacologic treatments. The checklist. Complexity of the intervention Description of the different components of the interventions and, when applicable, description of the procedure for tailoring the interventions Details of how the interventions were standardised Details of how adherence of care providers with the protocol was assessed or enhanced. Details of the experimental treatment and comparator as they were implemented. (New item) Blinding those administering co interventions method of blinding and description of the similarity of interventions 8

An extension for non-pharmacologic treatments. The checklist. Care providers and centers Eligibility criteria for participants and, when applicable, centres and those performing the interventions.. When applicable, a qualitative description of care providers (case volume, qualification, expertise, etc.) and centres (volume) in each group. Clustering effect How sample size calculation Statistical analysis 9

An extension for non-pharmacologic treatments. The flow diagram Randomized (n =.) Allocated to intervention (n = ) Received allocated intervention (n = ) Did not receive allocated intervention (give reasons) (n = ) Care providers (n = ), teams (n = ), centres (n= ) performing the intervention Number of patients treated by each care provider, team and centre (median = [IQR, min, max]) 10

An extension for non-pharmacologic treatments. The diffusion Boutron I, et al. Ann Intern Med 2008 58 and 254 time cited (Sept 5th 2011) 11

An extension for non-pharmacologic treatments. The dissemination CONSORT NPT Other CONSORT extension 2010 CONSORT checklist / diagram JAMA Yes, link to checklist Lancet Yes, harm and cluster Yes link to CONSORT website Yes, link to the publication Cluster, Herbal therapy, Noninferiority and equivalence RCTs Yes, link to CONSORT website BMJ Yes link to CONSORT website PlosMed Yes link to CONSORT website NEJM Ann Surg Yes link to CONSORT website Neurorehab Neural Repair Ref to 2010 publication Am J of Psychiatry Yes link to CONSORT 12 website Ann Intern Med

An extension for non-pharmacologic treatments. Impact No study assessing the impact of this extension Recent study on the reporting of flow diagram (Sally Hopewell et al.) Cross sectional review of all primary reports of randomized trials which include a CONSORT flow diagram indexed in PubMed core clinical journals from July to December 2009. 236 parallel group with flow diagram, 120 (51%) evaluated nonpharmacologic treatments No flow diagram reported according to the extension 13

Remaining challenges To update the extension for CONSORT NPT According to the CONSORT 2010 New developements on this topic 14

Remaining challenges To develop and evaluate different methods of implementation Instruction to authors Use of checklist completed by authors Systematic assessment of the compliance to the CONSORT statements before peer-review 15

Conclusion There is a need to improve transparency of NPT trials The implementation of extension of the CONSORT NPT by active policy is needed 16

Acknowledgments Mohit Bhandari, Marion Campbell, Philip Devereaux, Peter C. Gøtzsche, Teodor P.Grantcharov, Jeremy Grimshaw, Ethan A. Halm, Erik Hendriks, Asbjørn Hróbjartsson, John Ioannidis, Astrid James, Giselle Jones, Richard J Lilford, Robin McLeod, David Moher, Andrew J Molyneux, Victor M. Montori, Cynthia Mulrow, Amy Plint, Drummond Rennie, Peter M Rothwell, Paula P. Schnurr, Kenneth F Schulz, Christoph M Seiler, Judith Stephenson, Simon G Thompson, Graham Thornicroft, David Torgerson, Tom Treasure, Peter Tugwell 17